Zymeworks (ZYME) Completes Theravance Biopharma Acquisition, Eyes Growth in COPD Market

· gurufocus.com

On September 28, 2026, Zymeworks Inc (NASDAQ: ZYME) finalized its acquisition of Theravance Biopharma, a strategic move expected to boost revenue and cash flow

On September 28, 2026, Zymeworks Inc (NASDAQ: ZYME) finalized its acquisition of Theravance Biopharma, a strategic move expected to boost revenue and cash flow ...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI